Richard L. Chang

5.9k citations

124 papers · 4.8k indexed · h-index 42

Co-authors: Allan H. Conney Alexander W. Wood Haruhiko Yagi Wayne Levin Mou‐Tuan Huang Donald M. Jerina D. M. JERINA Harold L. Newmark
Topics: Carcinogens and Genotoxicity Assessment (29 papers)Pharmacogenetics and Drug Metabolism (15 papers)DNA Repair Mechanisms (14 papers)
Cited by: Pharmacology Cancer Research Biochemistry
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Journal of Clinical Oncology
Partner nations: United States Switzerland China

In The Last Decade

Richard L. Chang

123 papers receiving 4.4k citations

Peers

Countries citing papers authored by Richard L. Chang

Since Specialization

Citations

This map shows the geographic impact of Richard L. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard L. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard L. Chang more than expected).

Fields of papers citing papers by Richard L. Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard L. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard L. Chang. The network helps show where Richard L. Chang may publish in the future.

Co-authorship network of co-authors of Richard L. Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Richard L. Chang. A scholar is included among the top collaborators of Richard L. Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard L. Chang. Richard L. Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mutagenicity and tumorigenicity of the four enantiopure bay-region 3,4-diol-1,2-epoxide isomers of dibenz[a,h]anthracene 2013 ·Carcinogenesis ·Richard L. Chang,Alexander W. Wood,Min-Nung Huang,Jian Xie,Xiaoxing Cui,Kenneth R. Reuhl,Derek R. Boyd,Yong Lin,Weichung Shih,Suresh K. Balani,Haruhiko Yagi,D. M. JERINA,(unknown)	11
2	Quantification of Intracellular Proteins and Monitoring Therapy Using Flow Cytometry 2010 ·Current Drug Targets ·Richard L. Chang,Chen-Hsiung Yeh,Maher Albitar	4
3	Abstract #5456: Correlation between inhibition of the activity of poly(ADP-ribose) polymerase (PARP) in human peripheral blood mononuclear cells (PBMCs) and tumor biopsies following treatment with ABT-888, an inhibitor of PARP 2009 ·Cancer Research ·Shivaani Kummar,Larry Rubinstein,Robert J. Kinders,Jiuping Ji,Ralph E. Parchment,(unknown),Anthony J. Murgo,Alice P. Chen,Sonny Khin,Yiping Zhang,(unknown),Mary Ann Yancey,Deborah Allen,Yvonne Horneffer,Lamin Juwara,Richard L. Chang,Gary Gordon,Joseph E. Tomaszewski,James H. Doroshow	6
4	Detection of Chromosome Translocations by Bead-Based Flow Cytometry 2007 ·Methods in molecular biology ·Huai En Huang Chan,Iman Jilani,Richard L. Chang,Maher Albitar	4
5	Measuring Humanized Antibodies in Plasma of Patients Treated With Antibody-Based Therapy Using Bead-Based Flow Cytometry 2007 ·Methods in molecular biology ·Huai En Huang Chan,Iman Jilani,Richard L. Chang,Maher Albitar	3
6	Inhibitory Effects of 12-O-Tetradecanoylphorbol-13-acetate Alone or in Combination with All-trans Retinoic Acid on the Growth of Cultured Human Pancreas Cancer Cells and Pancreas Tumor Xenografts in Immunodeficient Mice 2005 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown),Xi Zheng,Xiao Cui,(unknown),(unknown),Junghan Suh,Arnold B. Rabson,Richard L. Chang,Weichung Joe Shih,Yong Lin,Pamela L. Crowell,Yao Lü,Y R Lou,Allan H. Conney	13
7	Dose-dependent mutation profile in the c-Ha-ras proto-oncogene of skin tumors in mice initiated with benzo[a]pyrene 1999 ·Carcinogenesis ·(unknown),Richard L. Chang,Kathleen A. Merkler,(unknown),Xiao Cui,(unknown),Mou-Tuan Huang,(unknown),Yao-Ping Lu,You-Rong Lou,Donald M. Jerina,Allan H. Conney	25
8	Characterization of the mutational profile of (+)-7R,8S-dihydroxy-9S,10R-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene at the hypoxanthine (guanine) phosphoribosyltransferase gene in repair-deficient Chinese hamster V-H1 cells 1999 ·Carcinogenesis ·(unknown),Xiao Cui,Yao-Ping Lu,Haruhiko Yagi,Donald M. Jerina,(unknown),Richard L. Chang,Allan H. Conney,(unknown)	32
9	Some Perspectives on Dietary Inhibition of Carcinogenesis: Studies with Curcumin and Tea 1997 ·Experimental Biology and Medicine ·Allan H. Conney,Y R Lou,Jian Xie,T. Osawa,H L Newmark,(unknown),Richard L. Chang,Mou‐Tuan Huang	106
10	Metastatic gastrinomas: localization with selective arterial injection of secretin. 1996 ·Radiology ·Fathia Gibril,John L. Doppman,Richard L. Chang,H. Christian Weber,B Termanini,R. T. Jensen	40
11	High-performance liquid chromatography separation of hydroxylated estradiol metabolites: formation of estradiol metabolites by liver microsomes from male and female rats. 1995 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown),Richard L. Chang,Robert T. Rosen,John J. Lech,A. H. Conney	50
12	Studies on the Metabolism of Benzo[a]Pyrene and Dose-Dependent Differences in the Mutagenic Profile of Its Ultimate Carcinogenic Metabolite 1994 ·Drug Metabolism Reviews ·Allan H. Conney,Richard L. Chang,Donald M. Jerina,(unknown)	125
13	Mutagenic selectivity at the HPRT locus in V-79 cells: comparison of mutations caused by bay-region benzo[a]pyrene 7,8-diol-9,10-epoxide enantiomers with high and low carcinogenic activity 1994 ·Carcinogenesis ·(unknown),Richard L. Chang,Ewa E. Hennig,Xiao Cui,Kathleen A. Merkler,Ching-Quo Wong,Haruhiko Yagi,D. M. JERINA,Allan H. Conney	56
14	Bacterial and mammalian cell mutagenicity of four optically active bay-region 10,11-diol-8,9-epoxides of the nitrogen heterocycle dibenz (a,h) acridine 1993 ·Carcinogenesis ·Richard L. Chang,(unknown),Ching-Quo Wong,Subodh Kumar,(unknown),Harish C. Sikka,(unknown),(unknown),Allan H. Conney,Alexander W. Wood	7
15	Inhibitory effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced increase in ornithine decarboxylase mRNA in mouse epidermis 1993 ·Carcinogenesis ·Yao-Ping Lu,Richard L. Chang,Mou‐Tuan Huang,Allan H. Conney	56
16	Effects of Captopril on the Distribution of Left Ventricular Output with Ventricular Septal Defect 1988 ·Pediatric Research ·Mark M. Boucek,Richard L. Chang	5
17	Evidence that benzo(a)anthracene 3,4-diol-1,2-epoxide is an ultimate carcinogen on mouse skin. 1978 ·PubMed ·Wayne Levin,Dhiren R. Thakker,Alexander W. Wood,Richard L. Chang,Roland E. Lehr,D. M. JERINA,Allan H. Conney	68
18	Evidence for bay region activation of chrysene 1,2-dihydrodiol to an ultimate carcinogen. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Wayne Levin,Alexander W. Wood,Richard L. Chang,Haruhiko Yagi,He Duck Mah,D. M. Jerina,A. H. Conney	42
19	Marked differences in the tumor-initiating activity of optically pure (+)- and (-)-trans-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene on mouse skin. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Wayne Levin,Alexander W. Wood,Richard L. Chang,Thomas J. Slaga,Haruhiko Yagi,D. M. Jerina,A. H. Conney	79
20	High carcinogenicity of 2-hydroxybenzo(a)pyrene on mouse skin. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Peter G. Wislocki,Richard L. Chang,Alexander W. Wood,Wayne Levin,Haruhiko Yagi,Óscar Hernández,He Duck Mah,Patrick M. Dansette,Donald M. Jerina,Allan H. Conney	43

About Richard L. Chang

Richard L. Chang is a scholar working on Cancer Research, Biochemistry and Pharmacology, having authored 124 papers that have together received 4.8k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (29 papers), Pharmacogenetics and Drug Metabolism (15 papers) and DNA Repair Mechanisms (14 papers). The work is most often cited by research in Pharmacology (887 citations), Cancer Research (1.5k citations) and Biochemistry (358 citations). Richard L. Chang has collaborated with scholars based in United States, Switzerland and China. Frequent co-authors include Allan H. Conney, Alexander W. Wood, Haruhiko Yagi, Wayne Levin, Mou‐Tuan Huang, Donald M. Jerina, D. M. JERINA, Harold L. Newmark, Dhiren R. Thakker and Roland E. Lehr. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact